HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Australia's Codeine Reverse-Switch “Vindicated” By 50% Drop In Supply

Executive Summary

A 50% drop in the supply of codeine-containing medicines in Australia last year shows that the decision to reverse-switch the drug was correct, according to the Australian Medical Association.   

Related Content

GSK/Pfizer Tie-Up Granted Clearance In Australia and New Zealand
Australian Industry Welcomes Possible Oral Contraceptive Switch
Pharmaceutical Society Of Australia Wants Pharmacy To ‘Draw A Line In The Sand’ And Stop Supplying Homeopathy
Supplements Industry Under Threat In Australia With 'Made In' Claim Restrictions





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts